跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RED EYE WORKPLACE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RED EYE WORKPLACE
Authorized
STANDARD
RED EYE WORKPLACE
johnson & johnson inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4cb61bb1e03bff3c
Company
johnson & johnson inc
Type
Standard
Approval Details
Approval Id
4cb61bb1e03bff3c
Drug Approval Canada Name
RED EYE WORKPLACE
Product Name
RED EYE WORKPLACE
Status
Marketed
Status Date
2022-03-15
Original Market Date
2022-03-15
Din
02518228
Drug Class
Human
Dosage Form
Drops
Route Of Administration
Ophthalmic
Schedule
OTC
Ahfs
52:32.00
Atc Original
S01GA52 TETRYZOLINE, COMBINATIONS
Atc Name
s 01 ga 52
Aig Number
0227167001
Company Name
johnson & johnson inc
Company Address
88 Mcnabb Street, Markham, Ontario, Canada, L3R 5L2
Active Ingredients
TETRAHYDROZOLINE HYDROCHLORIDE
0.05 % / W/V
POLYETHYLENE GLYCOL 400
1 % / V/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4cb61bb1e03bff3c
Type
Standard
Back to Health Canada Approvals